Updated:
Merck & Co., Inc.
Merck & Co. Inc. Master Retirement Trust was established to deliver retirement benefits to eligible employees of the biopharmaceutical company.
Merck & Co., Inc.
Merck & Co. Inc. Master Retirement Trust was established to deliver retirement benefits to eligible employees of the biopharmaceutical company. The plan is based in Rahway, New Jersey and reports $11.544 billion in assets. The trust allocates across public equities, fixed income, and alternatives. Confirmed holdings include positions in Personalis, Moderna, Kymera Therapeutics, Transcarent, Unite Us, and PathAI. Geographic exposure centers on North America with additional commitments through MRL Ventures Fund in Europe. The trust employs no disclosed investment staff count. It maintains direct ownership of multiple U.S. and international manufacturing and research sites. No operational events from the last 24 months are recorded in available data. The pension structure separates retirement assets from the parent corporation's operating balance sheet while sharing the same executive leadership.
General information
Firm type
Pension Fund
Location
Region
North America
Country
United States
City
Rahway
Corporate office
126 East Lincoln Avenue, Rahway, NJ, United States
Principals
Robert M. Davis
Chairman, President, and CEO
Sector focus
Frequently asked questions
Who runs investment decisions at Merck & Co. Inc. Master Retirement Trust?
Robert M. Davis serves as Chairman, President, and CEO of the parent company. No separate CIO for the trust is named in the record.
What asset classes does the trust hold?
The trust holds public equities, fixed income, and a 3 percent allocation to private equity. It also owns direct real estate assets including manufacturing facilities.
Does the trust make direct investments or only fund commitments?
The trust participates in both direct holdings and commitments through vehicles such as Merck Global Health Innovation Fund and MRL Ventures Fund.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on pension funds?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: